| Having trouble reading this newsletter? Click here to see it in your browser. You are receiving this newsletter because you signed up from our web site. Click here to unsubscribe. |
 14 July 2009  |
 |
|
Dealmakers Newsletter Update - July 2009Sponsored this month by: BioNetwork 2009 Laguna Niguel, California, USA - October 5-7, 2009 BioNetwork offers you the opportunity to meet with VPs of Business Development, Licensing, and Alliance Management from top companies offering their insights Visit the conference website for more details
Editor's cornerHave you ever tried to find the partnering, licensing, business development section of a company's website? We have and often find it hidden away, inaccessible or worse not available. Since biopharma needs partnering to achieve successful product development and commercialization, why not have an industry standard URL for partnering information on a company website. We propose the following: All biopharma websites should place their partnering, licensing and business development information on a standardized Partnering homepage - www.companynamme.com/partnering - allowing all in the industry to know where to find relevant partnering information. Last month hosted the major Eurobiotechforum conference in Barcelona. Option-based deals were the talk of the event, providing an emerging alternative to licensing to manage risk. We have recently published a new report titled Option & Evaluation Agreements in Pharma and Biotech providing detailed understanding and analysis of how and why companies enter option and evaluation deals, plus access to actual option and evaluation agreements. NEW! Our industry round-up and in the news sections are updated daily online, providing you with the latest trends from the world's most respected publishers anddeal news direct from biopharma companies as they are announced. We have also updated our Scorecard Index feature that allows you to track the number of deals announced every month, using several subcategories:
You can keep track of deal announcements number using our Scorecard Index - bookmark for future reference. During June we published a brand new report: Oncology Partnering Agreements in Pharma, Biotech and Diagnostics, providing comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the worlds leading biopharma companies In addition, we have updated our popular Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition, providing the latest in best practice on the partnering process. All for now - enjoy the summer. -- Steve Poile -- In the newsThe following are just some of the deals involving bigpharma announced in the last few weeks: Deals of note so far in July 2009:
Keep posted on the latest deals and alliances with CurrentPartnering's In the news feature NEW! Partnering roundupJust some of the articles picked up by Roundup during July:
NEW: ScorecardLaunched last month is our new overview of partnering and M&A deals - Scorecard Index. Updated monthly - we will be updating our Scorecard Index - tracking partnering and M&A deals announced every month. In additon, we track the leading deals by value in the currect year, plus a compendium of top deals by value since 2000 - view details at Scorecard.
New and updated reportsNew report titles: CurrentPartnering has published new titles: Oncology Partnering Agreements in Pharma, Biotech and Diagnostics The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the worlds leading biopharma companies
Option & Evaluation Agreements in Pharma and Biotech The Option and Evaluation Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies Royalty Financing Agreements in Pharma, Biotech and Diagnostics The Royalty Financing Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals. Revised and updated reports: CurrentPartnering has revised and updated its most popular reports: Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition The Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered into by the worlds leading biopharma companies Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 2nd edition The Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies. Revised and updated 2nd edition Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition CurrentPartnering’s Practical Guide to Finding Partners in Pharma & Biotech provides a comprehensive overview of all the steps required to identify and secure partnering either for an in-licensing or out-licensing activity New from Datamonitor: Biotech Financing in the Credit Crisis: Strategies for a radically altered landscape Since the financial meltdown, the relationship between Pharma and Biotech has been turned on its head. Previously, pharma companies had no choice but to license Biotech drugs at high prices in order to fill their sparse late stage pipelines Best practice articlesMining Experiential Knowledge At Partnering Events - Part 1 When business development executives attend a euroPLX meeting (or any other partnering conference for that matter) they experience a learning process - more PanGenerika: A Gateway to Europe’s Pharmaceuticals Markets PanGenerika is a company that was created and registered in the Netherlands in June 2007 with the intention of easing the burden on pharmaceutical companies that want to enter the European market - more Collecting Payments Even If Your Patent Application Never Issues as a Patent This article introduces what should be considered in negotiating license agreements with pending patent application. It recommends the licensor to insert a de-escalating royalty clause and a clause regarding the “know-how” information to be protected from the uncertainty of the patent prosecution process - read more Is Silence Golden? Patents versus Secrecy at the Firm Level This article by Katrin Hussinger analyzes the importance of patenting versus secrecy. Based on the empirical analysis of product innovating firms in German manufacturing in 2000, it finds that patents are more important than secrecy to protect the income generated from sale of new products - read more here
Read all our partnering best practice articles. Forthcoming eventsHere are some of our suggested events for fall 2009: BioPharm America 2009 San Francisco, CA, USA - September 16-18, 2009 - more details Pharmaceutical Strategic Alliances 2009 New York City, NY, USA - September 21-23, 2009 - more details 8th Annual Portfolio Evaluation and Strategic Investment Decision-Making Philadelphia, PA, USA - September 22-23, 2009 - more details EuroBio 2009 Lille, France - September 23-25, 2009 - more details BioNetwork 2009 Laguna Niguel, California, USA - October 5-7, 2009 - more details 9th MedTech Investing Europe Conference London, United Kingdom - October 5-6, 2009 - more details BioEurope 2009 Vienna, Austria - November 2-4, 2009 - more details Therapeutic Area Partnerships 2009 Boston, MA, USA - November 17-19, 2009 - more details People on the moveThe following people have been reported on the move during June/July 2009: Geoffrey Parker, Sunil Patel, Scott Forrest, Richard White, George Siegel to name just a few read more about the latest people on the move If you have news about a business development executive who is on the move - let us know Partnering resourcesCurrent Partnering maintains and regularly updates this list of useful resources for dealmakers across all industries. The following topic areas are available - updated regularly:
Missing something? Let us know and we will include all appropriate resources.
Contact usSteve Poile, Editor Web: http://www.CurrentPartnering.com Mail: CurrentPartnering, Allanmere House, 6 Hobgate, York, YO24 4HF, United Kingdom Tel: +44 7896 656732 Fax: +44 8703 305993
Advertizing and sponsorshipCurrentPartnering offers several advertising options, enabling your product or service to be promoted to our global business development audience - further details available online. or contact us to discuss your requirements.
About CurrentPartneringCurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers
|
|
|
|
Sponsored by: 
CurrentPartnering reports
|
|
|
||
|
 |
|